Oric Pharmaceuticals Inc

NASDAQ ORIC

Data sourced from iex and EODHD
Download Data

Oric Pharmaceuticals Inc Cash Flow Statement 2019 - 2024

This table shows the Cash Flow Statement for Oric Pharmaceuticals Inc going from 2019 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Income
M -25 -28 -25 -23 -24 -21 -25 -20 -23 -23 -18 -21 -17 -28 -26 -11 -9 -8 -7 -6 -6
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-Cash Items (Other)
M 9 1 -2 -1 -1 -1 0 0 0 -1 0 0 0 7 13 -109 - 0 0 0 -
Operating Cash Flow
M -30 -24 -20 -21 -21 -15 -19 -18 -23 -16 -12 -16 -15 -18 -10 -10 -8 -7 -5 -5 -6
Capital Expenditures
M 0 0 0 0 0 0 0 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0
Net Acquisitions
M - - - - - - - - - - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - - - - - - - - - 0 - 0 0 0
Investing Cash Flow
M - - - - - - - - - - - - - - - - 0 - 0 0 0
Repayment/Issuance of Debt (Net)
M - - - - - - - - - - - - - - - - - - - - -
Equity Repurchase (Common, Net)
M - -17,220 8,620 8,601 - 1 0 0 0 1 50 0 0 - - - 0 - - - 15
Dividends Paid
M - - - - - - - - - - - - - - - - - - - - -
Other Financial Activities
M 0 0 -8,620 -8,601 13 -1 0 0 0 1 -1 0 0 -8 0 127 -2 0 6 50 15
Financing Cash Flow
M 0 0 -8,620 -8,601 13 -1 0 0 0 1 -1 0 0 -8 0 127 -2 0 6 50 15
Exchange Rate Adjustment
M - - - - - - - - - - - - - - - - - - - - -
Beginning Cash
M 23 26 104 59 67 30 50 113 226 242 170 104 78 62 197 79 89 96 96 52 43
Ending Cash
M 56 23 27 104 59 67 30 50 113 226 242 170 104 78 62 197 79 89 96 96 52
Stock-Based Compensation
M 5 4 4 4 4 3 3 4 4 3 3 3 3 2 2 1 1 0 0 0 0
Issuance/Purchase of Shares
M - -17,220 8,620 8,601 - 1 0 0 0 1 50 0 0 - - - 0 - - - 15
Capital Stock Change
M 125 0 0 85 - 25 - - - 0 50 - - - - - - - - - -
Working Capital
M 309 192 213 254 178 195 185 221 227 225 281 255 272 288 182 193 75 85 - - -
Free Cash Flow
M -31 -25 -20 -22 -21 -16 -20 -18 -23 -17 -12 -16 -15 -18 -10 -10 -8 -7 -6 -6 -6

StockViz Staff

September 20, 2024

Any question? Send us an email